Healthcare Value Capital’s Adamas Pharmaceuticals ADMS Stock Holding History

Healthcare Value Capital’s Portfolio ADMS Stock Details ADMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$491K	Hold	100,000	–	–	0.97%	22
2021 Q2	$528K	Hold	100,000	–	–	1.05%	22
2021 Q1	$480K	Hold	100,000	–	–	1.07%	21
2020 Q4	$433K	Hold	100,000	–	–	1.46%	16
2020 Q3	$412K	Buy	+100,000	New	+$387K	1.36%	18
2019 Q4	–	Sell	-200,000	Closed	-$957K	–	23
2019 Q3	$1.02M	Hold	200,000	–	–	1.85%	14
2019 Q2	$1.24M	Buy	200,000 +100,000	+100%	+$575K	2.33%	14
2019 Q1	$711K	Buy	+100,000	New	+$899K	2.74%	10

Other funds holding ADMS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

CCPM

Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Healthcare Value Capital's ADMS Position: Q3 2021 in Review

Healthcare Value Capital held its Adamas Pharmaceuticals (ADMS) position steady in Q3 2021 at 100,000 shares worth $491K. The position accounts for 0.97% of the portfolio, ranked #22.

Healthcare Value Capital first reported a position in ADMS in Q1 2019 and has held it in 8 quarters since. The position peaked at $1.24M in Q2 2019. 63 funds tracked by Wall St. Rank hold ADMS as of Q3 2021.

Healthcare Value Capital held 100,000 shares of Adamas Pharmaceuticals worth $491K as of Q3 2021.
Healthcare Value Capital left its Adamas Pharmaceuticals share count unchanged in Q3 2021.
Adamas Pharmaceuticals made up 0.97% of Healthcare Value Capital's portfolio in Q3 2021, its #22 holding.
Healthcare Value Capital first reported a position in Adamas Pharmaceuticals in Q1 2019 and has held it in 8 quarters since.
Healthcare Value Capital's Adamas Pharmaceuticals position peaked at $1.24M in Q2 2019.
63 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q3 2021.

Based on Healthcare Value Capital's 13F filing for Q3 2021, filed 15 Nov 2021.